ID

31474

Descrição

Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL); ODM derived from: https://clinicaltrials.gov/show/NCT00944905

Link

https://clinicaltrials.gov/show/NCT00944905

Palavras-chave

  1. 26/08/2018 26/08/2018 -
  2. 27/08/2018 27/08/2018 - Sarah Riepenhausen
Titular dos direitos

Bristol-Myers Squibb

Transferido a

27 de agosto de 2018

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Renal Cell Carcinoma and B-Cell Non-Hodgkin's Lymphoma NCT00944905

Eligibility Renal Cell Carcinoma and B-Cell Non-Hodgkin's Lymphoma NCT00944905

Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
eastern cooperative oncology group (ecog) performance status of 0 to 2
Descrição

ECOG performance status

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1520224
criteria specific for each tumor type: for clear cell renal cell carcinoma (ccrcc): advanced or recurrent disease. must have failed at least 1 prior systemic therapy
Descrição

Advanced or recurrent clear cell renal cell carcinoma, prior therapy failed

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0279702
UMLS CUI [1,2]
C0679246
UMLS CUI [1,3]
C1514463
UMLS CUI [1,4]
C0231175
UMLS CUI [2,1]
C0279702
UMLS CUI [2,2]
C0277556
UMLS CUI [2,3]
C1514463
UMLS CUI [2,4]
C0231175
criteria specific for each tumor type: for b-cell non-hodgkin's lymphoma (b-nhl): must have failed at least 1 prior systemic therapy
Descrição

b-nhl with prior systemic therapy failed

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0024305
UMLS CUI [1,2]
C1514463
UMLS CUI [1,3]
C0231175
measurable disease criteria by tumor type: for ccrcc: at least 1 unidimensional measurable lesion
Descrição

Clear cell renal cell carcinoma: measurable lesion

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0279702
UMLS CUI [1,2]
C1513041
measurable disease criteria by tumor type: for b-nhl: at least 1 bidimensionally measurable lesion
Descrição

B-nhl: measurable bidimensional lesion

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0024305
UMLS CUI [1,2]
C1513041
UMLS CUI [1,3]
C1705052
prior therapies for advanced/recurrent ccrcc or relapsed/refractory b-nhl or have become intolerant to a systemic therapy
Descrição

Prior therapy for advanced/recurrent clear cell renal cell carcinoma or relapsed/refractory b-nhl

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0279702
UMLS CUI [1,3]
C0679246
UMLS CUI [2,1]
C1514463
UMLS CUI [2,2]
C0279702
UMLS CUI [2,3]
C0277556
UMLS CUI [3,1]
C1514463
UMLS CUI [3,2]
C0855089
UMLS CUI [4,1]
C1514463
UMLS CUI [4,2]
C0855090
UMLS CUI [5,1]
C1744706
UMLS CUI [5,2]
C1515119
provide archived or fresh tumor tissue for cd70 status. subjects must be cd70+
Descrição

CD70 antigen positive

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1514241
UMLS CUI [1,2]
C0215991
provision of fresh tissue (pre-treatment and on-treatment) for exploratory analysis is mandatory for at least 5 and a maximum of 10 b-nhl subjects
Descrição

Provision of fresh tumor tissue

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1292533
UMLS CUI [1,2]
C2827486
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior therapy with an anti-cd70 antibody
Descrição

Prior therapy with an anti-cd70 antibody

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0281176
UMLS CUI [1,3]
C0215991
history of severe hypersensitivity reactions to other monoclonal antibodies
Descrição

Hypersensitivity to monoclonal antibodies

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0003250
active or untreated central nervous system lymphoma
Descrição

CNS lymphoma

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0280803
active infection (viral, bacterial, or fungal)
Descrição

Infection

Tipo de dados

boolean

Alias
UMLS CUI [1]
C3714514
evidence of bleeding diathesis or coagulopathy
Descrição

Bleeding diathesis or coagulopathy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0005779
active autoimmune disease requiring immunosuppressive therapy
Descrição

Concomitant autoimmune disease

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0021079
UMLS CUI [1,2]
C0004364
known current drug or alcohol abuse
Descrição

Substance abuse

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0013146
UMLS CUI [2]
C0085762

Similar models

Eligibility Renal Cell Carcinoma and B-Cell Non-Hodgkin's Lymphoma NCT00944905

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status of 0 to 2
boolean
C1520224 (UMLS CUI [1])
Advanced or recurrent clear cell renal cell carcinoma, prior therapy failed
Item
criteria specific for each tumor type: for clear cell renal cell carcinoma (ccrcc): advanced or recurrent disease. must have failed at least 1 prior systemic therapy
boolean
C0279702 (UMLS CUI [1,1])
C0679246 (UMLS CUI [1,2])
C1514463 (UMLS CUI [1,3])
C0231175 (UMLS CUI [1,4])
C0279702 (UMLS CUI [2,1])
C0277556 (UMLS CUI [2,2])
C1514463 (UMLS CUI [2,3])
C0231175 (UMLS CUI [2,4])
b-nhl with prior systemic therapy failed
Item
criteria specific for each tumor type: for b-cell non-hodgkin's lymphoma (b-nhl): must have failed at least 1 prior systemic therapy
boolean
C0024305 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
Clear cell renal cell carcinoma: measurable lesion
Item
measurable disease criteria by tumor type: for ccrcc: at least 1 unidimensional measurable lesion
boolean
C0279702 (UMLS CUI [1,1])
C1513041 (UMLS CUI [1,2])
B-nhl: measurable bidimensional lesion
Item
measurable disease criteria by tumor type: for b-nhl: at least 1 bidimensionally measurable lesion
boolean
C0024305 (UMLS CUI [1,1])
C1513041 (UMLS CUI [1,2])
C1705052 (UMLS CUI [1,3])
Prior therapy for advanced/recurrent clear cell renal cell carcinoma or relapsed/refractory b-nhl
Item
prior therapies for advanced/recurrent ccrcc or relapsed/refractory b-nhl or have become intolerant to a systemic therapy
boolean
C1514463 (UMLS CUI [1,1])
C0279702 (UMLS CUI [1,2])
C0679246 (UMLS CUI [1,3])
C1514463 (UMLS CUI [2,1])
C0279702 (UMLS CUI [2,2])
C0277556 (UMLS CUI [2,3])
C1514463 (UMLS CUI [3,1])
C0855089 (UMLS CUI [3,2])
C1514463 (UMLS CUI [4,1])
C0855090 (UMLS CUI [4,2])
C1744706 (UMLS CUI [5,1])
C1515119 (UMLS CUI [5,2])
CD70 antigen positive
Item
provide archived or fresh tumor tissue for cd70 status. subjects must be cd70+
boolean
C1514241 (UMLS CUI [1,1])
C0215991 (UMLS CUI [1,2])
Provision of fresh tumor tissue
Item
provision of fresh tissue (pre-treatment and on-treatment) for exploratory analysis is mandatory for at least 5 and a maximum of 10 b-nhl subjects
boolean
C1292533 (UMLS CUI [1,1])
C2827486 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Prior therapy with an anti-cd70 antibody
Item
prior therapy with an anti-cd70 antibody
boolean
C1514463 (UMLS CUI [1,1])
C0281176 (UMLS CUI [1,2])
C0215991 (UMLS CUI [1,3])
Hypersensitivity to monoclonal antibodies
Item
history of severe hypersensitivity reactions to other monoclonal antibodies
boolean
C0020517 (UMLS CUI [1,1])
C0003250 (UMLS CUI [1,2])
CNS lymphoma
Item
active or untreated central nervous system lymphoma
boolean
C0280803 (UMLS CUI [1])
Infection
Item
active infection (viral, bacterial, or fungal)
boolean
C3714514 (UMLS CUI [1])
Bleeding diathesis or coagulopathy
Item
evidence of bleeding diathesis or coagulopathy
boolean
C0005779 (UMLS CUI [1])
Concomitant autoimmune disease
Item
active autoimmune disease requiring immunosuppressive therapy
boolean
C0021079 (UMLS CUI [1,1])
C0004364 (UMLS CUI [1,2])
Substance abuse
Item
known current drug or alcohol abuse
boolean
C0013146 (UMLS CUI [1])
C0085762 (UMLS CUI [2])

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial